News

A lower medical cost ratio lifted operating earnings to $8 billion, up from $5.2 billion a year ago

US equity markets were mostly tracking in the red before the opening bell Thursday as traders await

The health insurance giant posted adjusted earnings of $6.38 per share, well above Wall Street estimates, and lifted its full-year adjusted profit guidance to $19.50–$20.00 per share

Semiconductor stocks are dragging Nasdaq futures lower, while UnitedHealth stock jumped 4% after topping earnings expectations

Health insurance company UnitedHealth (NYSE:UNH) announced better-than-expected revenue in Q2 CY2026, but sales were flat year on year at $112 billion. Its non-GAAP profit of $6.38 per share was 30.6% above analysts’ consensus estimates.

UnitedHealth Group is back in focus as analysts adjust their price targets, with updated fair value estimates now set at US$424.23 compared with the prior US$411.31. Behind these tweaks, recent research has weighed steadier views on Medicare Advantage, Medicaid and ACA exchanges against mixed opinions on medical cost pressures and the durability of current trends. As you read on, you will see how these shifting signals feed into the evolving analyst narrative and what to watch next in...

UnitedHealth Group crushed Q2 earnings forecasts amid lower-than-expected benefit costs and gave a big boost to its full-year outlook. Humana, Centene and CVS Health all got a sizable lift from the warm reception for UnitedHealth's earnings report.

Investing.com -- UnitedHealth Group (NYSE:UNH) reported second quarter results that exceeded analyst expectations across earnings, revenue and guidance, sending shares up 7% premarket as investors responded positively to the healthcare giant's improved outlook.

The healthcare giant posts better-than-expected second-quarter earnings and hikes its full-year guidance.

Investors parsed signals on the AI build-out, consumer spending, geopolitical uncertainty, and more in a packed Thursday session.

Investors were set to parse signals on the AI build-out, consumer spending, geopolitical uncertainty, and more in a packed Thursday session.

By Amina Niasse NEW YORK, July 16 (Reuters) - UnitedHealth Group raised on Thursday its 2026 profit forecast as the company tightened spending on medical costs and improved operating income in its

↘️ Dell Technologies (DELL): The stock extended its decline in premarket trading following a double-digit drop yesterday, driven by mounting fears of an industry-wide AI overbuild. ↘️ Taiwan Semiconductor Manufacturing (TSM): The chip maker’s U.

Stocks were on track to slide Thursday as the artificial-intelligence trade lost some momentum, with investors opting to take profit even though the broader macroeconomic environment is looking good for the market. Nasdaq 100 futures dropped 0.6%. Investors are questioning how long the AI boom will last–but still finding plenty of places to put their money in the market.

Today Earnings (a.m): UnitedHealth, GE Aerospace, U.S. Bancorp, Citizens Financial, Abbott Laboratories, State Street, Taiwan Semiconductor Manufacturing Earnings (p.m.): Netflix, Intuitive Surgical Economic data: Weekly jobless claims, Philadelphia Fed business-outlook survey, retail sales, pending home sales index, business inventories Fed speakers: Fed Vice Chair Philip Jefferson is expected to speak, as is Dallas Fed President Lorie Logan.

UnitedHealth Group’s stock fell hard in 2025. When the healthcare insurer reports second-quarter results Thursday, the company’s 2026 bounceback has investors eager for confirmation that medical spending trends are in hand. UnitedHealth has notched a series of wins heading into earnings season.

Dell, Sandisk and Micron led an AI sell-off, masked by megacaps such as Apple. SpaceX undercut its IPO price. Taiwan Semi, GE Aerospace earnings are due.

Elevance Health beats Q2 EPS and revenue estimates, raises 2026 adjusted EPS outlook despite lower earnings, softer membership and higher expenses.

UnitedHealth (UNH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Health insurance shares moved sharply lower in premarket trading after Elevance Health’s (NYSE:ELV) latest quarterly results revealed continued pressure on margins within its core Health Benefits business, raising concerns that similar challenges could affect the wider managed-care sector. Margin weakness overshadows earnings beatAlthough Elevance reported second-quarter earnings and revenue that comfortably exceeded analysts’ expectations, investors focused on the deterioration in profitability

According to the average brokerage recommendation (ABR), one should invest in UnitedHealth (UNH). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

Elevance Health topped Q2 earnings estimates Wednesday, despite falling medical membership, but profit was boosted by one-time "below-the-line" factors and the full-year outlook was underwhelming. ELV stock tumbled, making it among the S&P 500's early laggards. Molina Healthcare, another S&P 500 managed care stock, joined Elevance among the biggest laggards performers in pre-market trading.

Stock Market Today: The Dow Jones index wavered Wednesday ahead of key inflation data. ASML stock jumped on earnings.

Investing.com -- Elevance Health’s Health Benefits operating profit collapsed in the second quarter of 2026, igniting a broad premarket selloff across the managed-care sector even as the insurer’s headline earnings handily beat estimates and full-year guidance was lifted.

Health insurance company UnitedHealth (NYSE:UNH) will be announcing earnings results this Thursday before market open. Here’s what you need to know.

Three stocks that stand out ahead of their upcoming Q2 reports on Thursday, July 16 are GE Aerospace (GE), Taiwan Semiconductor (TSM), and UnitedHealth Group (UNH).

The U.S. Department of Justice has expanded an antitrust investigation to include UnitedHealth Group's Claritev unit. The Claritev review is part of broader DOJ scrutiny of healthcare industry practices and market competition. This development adds a fresh layer of regulatory attention for UnitedHealth Group (NYSE:UNH) beyond routine oversight. UnitedHealth Group, one of the largest managed care and healthcare services companies in the U.S., spans insurance, care delivery, and data-driven...

Elevance Health is breaking the Medicare Advantage curse, and the insurer’s earnings could show it on Wednesday. Health insurer stocks have rallied this year after a tough run of rising medical costs that hampered earnings in 2024 and 2025. The results come just a day ahead of the monster of the industry, UnitedHealth Group Wall Street will be watching to see if these two companies can keep the momentum going.

(Updates with Claritev's response in the fourth paragraph.) The US Justice Department recently se

(Update with the Justice Department's response to a request for comment in the third paragraph.)